摘要
目的评价嘎日迪五味丸联合氯雷他定治疗慢性荨麻疹的疗效与安全性。方法将125例慢性荨麻疹的患者,随机分为治疗组(68例)和对照组(57例),治疗组:患者每早1次口服氯雷他定10mg,嘎日迪五味丸3～5粒。对照组:每早1次口服氯雷他定10mg,疗程均为6周。结果治疗组、对照组有效率分别为85.30%,52.38%,经统计学处理,差异有极显著性。结论嘎日迪五味丸联合氯雷他定治疗慢性荨麻疹安全、有效。
Objective To evaluate the efficacy and safety of a combination thrapy with Garidi Wuwei Wan and Loratadine on chronic urticaria. Methods 125 patients with chronic urticaria were randomly divided into treatment group （68 subjects） and control group （57 Subjects）. In the treatment group, take orally Loratadine 10mg once daily, and Garidi Wuwei Wan 3-5 grain. In the control group, take orally Loratadine 10mg once daily. The thrapy period was 6 weeks for both groups. Results The effective rate was 85.30% for the treatment group and 52.38% for the control group, with a significant difference. Conclusion The combination of Garidi Wuwei Wan and Loratadine has an obvious therapeutic effectiveness and is safe in the treatment of patients with s chronic urticaria.
出处
《中国现代药物应用》
2009年第15期38-39,共2页
Chinese Journal of Modern Drug Application
